Atlas Trials

Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer Patients

Clinical trial NCT06473259 · RECRUITING

Trial details

NCT number
NCT06473259
Sponsor
Santa Chiara Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Prostate CancerHormone Sensitive Prostate CancerMetastatic Tumor
Start date
2016-12-16
Primary completion
2026-12-01
Enrollment
3000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.